A to Z Health Guide 2007
The scientific bulletin of the year may be the stem-cell breakthrough. But 2007 provided a whole alphabet of big medical news. TIME's A-to-Z guide reviews them
—By Coco Masters, Alice Park, Carolyn Sayre, Tiffany Sharples, Alexandra Silver and Kate Stinchfield
The asthma drug Xolair now has a black-box warning — the strongest alert the FDA imposes — since reports showed the risk of anaphylaxis, an extreme allergic reaction, to be greater than originally thought. The reaction is rare but potentially very dangerous. Xolair, known generically as omalizumab, was approved in 2003 to treat moderate to severe allergic asthma in some patients 12 and older for whom inhaled steroids aren't sufficient. Users and their doctors must balance the benefits and the perils of the drug.
View the full list for "A to Z Health Guide 2007"Latest Lists
Most Popular »
- Israel vs. Hizballah: Drumbeats of War
- Super-Earth: Astronomers Find a Watery New Planet
- Under U.S. Pressure, Pakistan Balks at Helping on Afghan Taliban
- America's Most Wanted Teenage Bandit
- Why Home Churches are Filling Up
- Study: European Muslims Feel Shut Out
- Proposed 'Botox Tax' Draws Wide Array of Opponents
- Church Group Attacks Christmas Commercialism
- Rattled by Iran, Arab Regimes Draw Closer
- Crazy Heart Review: Jeff Bridges Abides
- Singapore: 10 Things to Do in 24 Hours
- Super-Earth: Astronomers Find a Watery New Planet
- Majority U.S. Population Non-White by 2050
- Church Group Attacks Christmas Commercialism
- Uganda's Anti-Gay Bill: Inspired by the U.S.
- Tax Reform Means Working Moms Do Less Housework
- What Houston's Gay Mayor Means for Texas
- Sex, Television and Berlusconi's Path to Power
- On Scene: With Uganda's Anti-Gay Movement
- Testosterone: Not Always an Aggression Booster
RSS